The Application of Peptide Nucleic Acids (PNA) in the Inhibition of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Gene Expression in a Cell-Free Transcription/Translation System
International Journal of Molecular Sciences · 25.01.2024 · 25 (3) · 1463
DOI: 10.3390/ijms25031463 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.01.2024. Verfasst von Agnieszka Polak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Science in Katowice, Medical University of Silesia, Medykow 18, 40-752 …. Hauptthemen laut MEDLINE: Hypercholesterolemia, Peptide Nucleic Acids, PCSK9 Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia, Univeristy of Gdańsk, University of Gdansk.
Abstract (Originalsprache)
Proprotein convertase subtilisin/kexin 9 (PCSK9) is a protein that plays a key role in the metabolism of low-density lipoprotein (LDL) cholesterol. The gain-of-function mutations of the PCSK9 gene lead to a reduced number of surface LDL receptors by binding to them, eventually leading to endosomal degradation. This, in turn, is the culprit of hypercholesterolemia, resulting in accelerated atherogenesis. The modern treatment for hypercholesterolemia encompasses the use of biological drugs against PCSK9, like monoclonal antibodies and gene expression modulators such as inclisiran—a short, interfering RNA (siRNA). Peptide nucleic acid (PNA) is a synthetic analog of nucleic acid that possesses a synthetic peptide skeleton instead of a phosphate–sugar one. This different structure determines the unique properties of PNA (e.g., neutral charge, enzymatic resistance, and an enormously high affinity with complementary DNA and RNA). Therefore, it might be possible to use PNA against PCSK9 in the treatment of hypercholesterolemia. We sought to explore the impact of three selected PNA oligomers on PCSK9 gene expression. Using a cell-free transcription/translation system, we showed that one of the tested PNA strands was able to reduce the PCSK9 gene expression down to 74%, 64%, and 68%, as measured by RT–real-time PCR, Western blot, and HPLC, respectively. This preliminary study shows the high applicability of a cell-free enzymatic environment as an efficient tool in the initial evaluation of biologically active PNA molecules in the field of hypercholesterolemia research. This cell-free approach allows for the omission of the hurdles associated with transmembrane PNA transportation at the early stage of PNA selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Science in Katowice, Medical University of Silesia, Medykow 18, 40-752 Katowice, Poland.
- Laboratory of Chemistry of Biologically Active Compounds, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland.
ORCID-Profile: Agnieszka Polak, Łukasz Bułdak, Jarosław Ruczyński, Piotr Mucha, Bogusław Okopień
Förderung
- Medical University of Silesia
- Univeristy of Gdańsk
- University of Gdansk
Zitieren
APA
Polak, A., Machnik, G., Bułdak, Ł., Ruczyński, J., Prochera, K., Bujak, O., Mucha, P., Rekowski, P., & Okopień, B. (2024). The Application of Peptide Nucleic Acids (PNA) in the Inhibition of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Gene Expression in a Cell-Free Transcription/Translation System. International Journal of Molecular Sciences, 25(3), 1463. https://doi.org/10.3390/ijms25031463
Vancouver
Polak A, Machnik G, Bułdak Ł, Ruczyński J, Prochera K, Bujak O, et al. The Application of Peptide Nucleic Acids (PNA) in the Inhibition of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Gene Expression in a Cell-Free Transcription/Translation System. International Journal of Molecular Sciences. 2024;25(3):1463. doi:10.3390/ijms25031463
BibTeX
@article{Polak2024,
author = {Polak, Agnieszka and Machnik, Grzegorz and Bułdak, Łukasz and Ruczyński, Jarosław and Prochera, Katarzyna and Bujak, Oliwia and Mucha, Piotr and Rekowski, Piotr and Okopień, Bogusław},
title = {The Application of Peptide Nucleic Acids (PNA) in the Inhibition of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Gene Expression in a Cell-Free Transcription/Translation System},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1463},
doi = {10.3390/ijms25031463}
}
EUVIMED